| Issue Date | Title | Author(s) |
| 2024 | Adaptive task recommendation based on reinforcement learning in mobile crowd sensing | Yang, Guisong; Xie, Guochen; Wang, Jingru; He, Xingyu; Gao, Li; Liu, Yunhuai |
| 2024 | Adaptive task recommendation based on reinforcement learning in mobile crowd sensing | Yang, Guisong; Xie, Guochen; Wang, Jingru; He, Xingyu; Gao, Li; Liu, Yunhuai |
| Oct-2022 | Antitumor Activity of the Zinc Oxide Nanoparticles Coated with Low-Molecular-Weight Heparin and Doxorubicin Complex In Vitro and In Vivo | Li, Zhuoyue; Zhang, Shuang; Liu, Man; Zhong, Ting; Li, Hui; Wang, Jingru; Zhao, Heng; Tian, Yubo; Wang, Hui; Wang, Jingwen; Xu, Meiqi; Wang, Shumin; Zhang, Xuan |
| Apr-2021 | CD3E as a new predictive biomarker of response to omalizumab treatment in asthma patients: Evidence from bioinformatic analysis | Zhang, Qing; Li, Hongwen; Gao, Shengnan; Wang, Jingru; Li, Chunxiao; Shu, Jun; Lin, Jiangtao |
| 27-Mar-2020 | Circulating Tumor DNA Predicts the Response and Prognosis in Patients With Early Breast Cancer Receiving Neoadjuvant Chemotherapy | Li, Shunying; Lai, Hongna; Liu, Jieqiong; Liu, Yujie; Jin, Liang; Li, Yudong; Liu, Fengtao; Gong, Yuhua; Guan, Yanfang; Yi, Xin; Shi, Qianfeng; Cai, Zijie; Li, Qian; Li, Ying; Zhu, Mengdi; Wang, Jingru; Yang, Yaping; Wei, Wei; Yin, Dong; Song, Erwei; Liu, Qiang |
| May-2024 | Domiciliary monitoring of exhaled nitric oxide in the management of asthma: a pilot study | Li, Hongwen; Lin, Jiangtao; Zhang, Qing; Wang, Jingru; Li, Chunxiao |
| Mar-2022 | Intelligent Nanodelivery System-Generated O-1(2) Mediates Tumor Vessel Normalization by Activating Endothelial TRPV4-eNOS Signaling | Zhang, Shuaiqiang; Li, Yuanhao; Li, Zhuoyue; Wang, Guangxue; Liao, Ai; Wang, Jingru; Li, Hui; Guo, Zefeng; Cheng, Boyang; Zhang, Xuan |
| 26-Nov-2021 | Interleukin-22 attenuates allergic airway inflammation in ovalbumin-induced asthma mouse model | Wang, Jingru; Gao, Shengnan; Zhang, Jingyuan; Li, Chunxiao; Li, Hongwen; Lin, Jiangtao |
| Feb-2024 | Multifunctional ZnO@DOX/ICG-LMHP Nanoparticles for Synergistic Multimodal Antitumor Activity | Li, Zhuoyue; Wang, Jingru; Liu, Junwei; Yu, Jianming; Wang, Jingwen; Wang, Hui; Wei, Qingchao; Liu, Man; Xu, Meiqi; Feng, Zhenhan; Zhong, Ting; Zhang, Xuan |
| 20-May-2020 | Platinum-based chemotherapy (chemo) with CS1001, an anti-PD-L1 antibody, for first-line advanced non-small cell lung cancer (NSCLC): Preliminary results from phase Ib cohorts of CS1001-101 study. | Zhou, Qing; Zhang, Qingyuan; Xu, Nong; Zhao, Yanqiu; Miao, Zhanhui; Shen, Lin; Gao, Quanli; Pei, Zhidong; Xia, Teddy; Wang, Jingru; Dai, Hangjun; Guo, Rong; Yang, Jianxin; Wu, Yi-Long |
| Jun-2021 | Real-world Effectiveness of Mepolizumab in Severe Eosinophilic Asthma: A Systematic Review and Meta-analysis | Li, Hongwen; Zhang, Qing; Wang, Jingru; Gao, Shengnan; Li, Chunxiao; Wang, Jianxin; Zhang, Shuhua; Lin, Jiangtao |
| Feb-2022 | Sugemalimab versus placebo, in combination with platinum-based chemotherapy, as first-line treatment of metastatic non-small-cell lung cancer (GEMSTONE-302): interim and final analyses of a double-blind, randomised, phase 3 clinical trial | Zhou, Caicun; Wang, Ziping; Sun, Yuping; Cao, Lejie; Ma, Zhiyong; Wu, Rong; Yu, Yan; Yao, Wenxiu; Chang, Jianhua; Chen, Jianhua; Zhuang, Wu; Cui, Jiuwei; Chen, Xueqin; Lu, You; Shen, Hong; Wang, Jingru; Li, Peiqi; Qin, Mengmeng; Lu, Dongmei; Yang, Jason |
| Sep-2021 | Variability of Type 2 inflammatory markers guiding biologic therapy of severe asthma: A 5-year retrospective study from a single tertiary hospital | Li, Hongwen; Zhang, Qing; Wang, Jingru; Gao, Shengnan; Li, Chunxiao; Wang, Jianxin; Zhang, Shuhua; Lin, Jiangtao |
